Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 183 entries
View as:

Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT02415777 Org: User:
Start: 10/31/14 End: 07/31/15 Due: 07/31/16

DWP450 for Treating Moderate to Severe Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT06354127 Org: User:
Start: 08/12/20 End: 01/25/21 Due: 01/25/22

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)

Phase: N/A Priority: Normal
NCT ID: NCT03184402 Org: User:
Start: 04/24/17 End: 07/31/17 Due: 07/31/18

Type 2 Diabetes Patients With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04221399 Org: User:
Start: 01/31/20 End: 10/31/20 Due: 10/31/21

Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

Phase: N/A Priority: Normal
NCT ID: NCT05411887 Org: User:
Start: 06/20/22 End: 06/30/25 Due: 06/30/26

Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT06427083 Org: User:
Start: 06/11/24 End: 06/30/26 Due: 06/30/27

Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation

Phase: N/A Priority: Normal
NCT ID: NCT01634308 Org: User:
Start: 06/30/10 End: 06/30/12 Due: 06/30/13

To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05926414 Org: User:
Start: 09/21/23 End: 06/30/25 Due: 06/30/26

Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients

Phase: N/A Priority: Normal
NCT ID: NCT03485534 Org: User:
Start: 01/23/18 End: 11/04/19 Due: 11/04/20

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT03009487 Org: User:
Start: 01/31/17 End: 04/30/18 Due: 04/30/19

DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT03369990 Org: User:
Start: 12/31/17 End: 10/31/18 Due: 10/31/19

A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05192395 Org: User:
Start: 04/15/22 End: 05/24/22 Due: 05/24/23

Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04477369 Org: User:
Start: 08/06/20 End: 09/30/20 Due: 09/30/21

Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02369302 Org: User:
Start: 01/31/15 End: 06/30/15 Due: 06/30/16

Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab

Phase: N/A Priority: Normal
NCT ID: NCT05184179 Org: User:
Start: 12/01/19 End: 08/16/22 Due: 08/16/23

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Phase: N/A Priority: Normal
NCT ID: NCT05505994 Org: User:
Start: 09/28/22 End: 09/30/24 Due: 09/30/25

The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients

Phase: N/A Priority: Normal
NCT ID: NCT01099891 Org: User:
Start: 03/31/10 End: 12/31/15 Due: 12/31/16

Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02332044 Org: User:
Start: 04/30/14 End: 01/31/15 Due: 01/31/16

Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04827472 Org: User:
Start: 01/20/21 End: 07/31/21 Due: 07/31/22

To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT04749173 Org: User:
Start: 11/21/20 End: 06/18/21 Due: 06/18/22

Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

Phase: N/A Priority: Normal
NCT ID: NCT02953405 Org: User:
Start: 12/31/15 End: 11/30/18 Due: 11/30/19

A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02561884 Org: User:
Start: 10/31/15 End: 10/31/15 Due: 10/31/16

Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04159961 Org: User:
Start: 12/24/19 End: 04/21/20 Due: 04/21/21

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06109259 Org: User:
Start: 11/06/23 End: 12/31/23 Due: 12/31/24

Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05574374 Org: User:
Start: 09/21/22 End: 03/06/23 Due: 03/06/24